The Weekly Roundup: Mental Health Awareness (10.12.18)
A provocative piece in Forbes this week suggested that illnesses related to mental health are one of the most common disabilities in the workplace and that we should encourage more discussion about it—well past “World Mental Health Day,” which occurred on Wednesday. According to the World Health Organization, about half of all mental illness begins by age 14, which makes developing coping strategies at a young age all the more important. But the problem is by no means isolated to any one age group. The impact of mental illness and its treatment in the workforce is also staggering. Pharmacy patients on certain medications or with a chronic illness are especially at risk. A recent study published by the International Journal of Geriatric Psychiatry looked at the high incidence of arthritis alongside depression in adults over 50 years of age. As you’d expect, the pharmacist’s role is growing. Check out these ideas on collaboration and these guidelines for screening and treatment.
Here are a few other stories that might be of interest:
- Checking out the competition: FTC asked to examine hospital/insurer contracts for potentially anti-competitive practices.
- Trade shows are a great way to learn about new products and purveyors, but they can be busy and overwhelming. Check out these tips for maneuvering efficiently around the trade show floor.
- Did you make it to Boston last week? NCPA weighed in on the new tax law’s pass-through deduction, among other topics, at this year’s NCPA Annual Convention. Check out event coverage here.
- Fighting vainly the old ennui? Check out these ideas for reinvigorating yourself mid-career.
- Not profitable enough, eh? Merck takes an unexpected pass on insulin biosimilar, leaving Mylan/Biocon and Eli Lilly/Boehringer Ingelheim to fight it out with Sanofi's Lantus. (Login required.)
- Room for improvement: Significant gaps in vaccination rates persist, according to the CDC.
- There’s a battle brewing in Pennsylvania. Former Governor Ed Rendell joins nonprofit dedicated to opening a safe injection site in Philadelphia.
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So, we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at firstname.lastname@example.org.
Sign up now to receive the latest independent
pharmacy news, tips, and resources.
The FDA made headlines this week with its surprise visit to e-cigarette powerhouse Juul, seizing thousands of pages of documents relating to marketing practices, particularly those aimed at teens. Five brands combine to represent 97 percent of the US market for e-cigarettes,...
Last week, the Senate passed the Patient Right to Know Drug Prices Act (S. 2554), swiftly followed by the House this week. The bill was designed to prevent gag clauses from limiting a pharmacist’s ability to tell patients if they will pay le...